PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: dental hygienist

Timetable: Initial (full) marketing authorisation ...

← Back to document page

The timetables in this document may be subject to revision Initial (Full) Marketing Authorisation application accelerated assessment timetables¬

  Marketing, Initial, Full, Authorisation, Marketing authorisation

Download Timetable: Initial (full) marketing authorisation ...

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Documents from same domain

Q12 Step 2b Technical and regulatory …

www.ema.europa.eu

ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36

  Product, Management, Lifecycle, Product lifecycle management

Guideline on good pharmacovigilance practices …

www.ema.europa.eu

9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)

  Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance

Guideline on good pharmacovigilance practices (GVP)

www.ema.europa.eu

Guideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25

  Good, Practices

Guideline on good pharmacovigilance practices …

www.ema.europa.eu

Guideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28

  Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance

Guideline for good clinical practice E6(R2)

www.ema.europa.eu

Guideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification

  Good, Practices, Clinical, Good clinical practice

Guideline for good clinical practice E6(R2)

www.ema.europa.eu

Guideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November

  Guidelines, Good, Practices, Clinical, Good clinical practice e6

Guideline on good pharmacovigilance practices …

www.ema.europa.eu

harmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product

  Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance

European Medicines Agency

www.ema.europa.eu

© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline

  Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised

products1/traditional herbal medicinal products

www.ema.europa.eu

There is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already

  Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1

Q7 Q&A - good manufacturing practice for active ...

www.ema.europa.eu

ICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37

  Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients

Related documents

Harmonised Technical Guidance for Non-eCTD …

esubmission.ema.europa.eu

This guidance does not apply to the electronic submission of p-marketing authorisation (re MA) information such as scientific advice, clinical trial applications, orphan drug designations, PIP submissions and related submission

  Guidance, Technical, Marketing, Harmonised, Authorisation, Harmonised technical guidance for non, Marketing authorisation

CONSOLIDATED VERSION OF DIRECTIVE …

www.allenovery.com

Version Date – 13 August 2013 © Allen & Overy 2013 CONSOLIDATED VERSION OF DIRECTIVE 2011/61/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

  2011, Directive, Consolidated, Version, Consolidated version of directive, Consolidated version of directive 2011

Timetable: Initial (full) marketing authorisation …

www.ema.europa.eu

The timetables in this document may be subject to revision Initial (Full) Marketing Authorisation application assessment timetables: Assessment of initial submission (120-day timetable)

  Applications, Marketing, Initial, Full, Authorisation, Marketing authorisation, Marketing authorisation application

Public Assessment Report UK National Procedure …

www.mhra.gov.uk

For the full list of all side effects reported with Nefopam Hydrochloride 30mg Film-coated Tablets see section 4 of the package leaflet. For the full list …

  Full, Nefopam

VICH and its role for authorisation of veterinary ...

www.oie.int

Page 3 What should be included in an application ‘dossier’? A full application for a marketing authorisation would normally comprise a comprehensive data package with quality documentation, safety data (including target animal safety

  Marketing, Full, Authorisation, Marketing authorisation

Bleeding - Scottish Palliative Care Guidelines

www.palliativecareguidelines.scot.nhs.uk

Scottish Palliative Care Guidelines ‐ Bleeding Copyright © 2014 NHS Scotland Page 3 of 5 Issue Date: 31/05/2014 Review Date: 31/05/2017 Medication Bleeding from ...

  Bleeding

Related search queries

Harmonised Technical Guidance for Non, Marketing authorisation, CONSOLIDATED VERSION OF DIRECTIVE, CONSOLIDATED VERSION OF DIRECTIVE 2011, Initial (full) marketing authorisation, Initial (Full) Marketing Authorisation application, Initial, Full, Nefopam, Authorisation, Bleeding